{
    "medicine_id": "047701b1e67840fbaf59a76179bfda2955abbda5",
    "platform_id": "DB08869",
    "metadata": {
        "name": "Egrifta 1 mg 1mL Kit",
        "composition": "1 mg 1mL Tesamorelin",
        "clinical_particulars": {
            "therapeutic_indications": "Tesamorelin acetate is a synthetic analogue of human hypothalamic Growth Hormone Releasing Factor hGRF indicated to induce and maintain a reduction of excess abdominal fat in HIV infected patients with lipodystrophy",
            "contraindications": {
                "disease": "Diarrhea congestive heart failure peripheral neuropathy and loss of mobility were the four serious adverse events reported during the clinical studies",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Tesamorelin stimulates growth hormone secretion and subsequently increases IGF 1 and IGFBP 3 levels",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00635",
                        "description": "The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Tesamorelin resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The serum concentration of the active metabolites of Prednisolone can be reduced when Prednisolone is used in combination with Tesamorelin resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The serum concentration of the active metabolites of Cortisone acetate can be reduced when Cortisone acetate is used in combination with Tesamorelin resulting in a loss in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}